CompanyScope

Illumina, Inc. balance sheet

Ticker ILMN · SEC CIK 1110803 · Latest fiscal year ended Dec 28, 2025

At the end of its fiscal year on Dec 28, 2025, Illumina, Inc. reported total assets of $6.64B and shareholders' equity of $2.72B. That works out to a current ratio of 2.08 (current assets ÷ current liabilities).

$0$5B$10B$15B$20BJan 2017: $4.28BDec 2017: $5.26BDec 2018: $6.96BDec 2019: $7.32BJan 2021: $7.58BJan 2022: $15.22BJan 2023: $12.25BDec 2023: $10.11BDec 2024: $6.30BDec 2025: $6.64BJan 2017Dec 2017Dec 2018Dec 2019Jan 2021Jan 2022Jan 2023Dec 2023Dec 2024Dec 2025
Illumina, Inc. total assets at fiscal year end, USD. Hover a bar for the exact figure.

Balance sheet at each fiscal year end

Fiscal year endedJan 2017Dec 2017Dec 2018Dec 2019Jan 2021Jan 2022Jan 2023Dec 2023Dec 2024Dec 2025
Total assets (USD)$4.28B$5.26B$6.96B$7.32B$7.58B$15.22B$12.25B$10.11B$6.30B$6.64B
Current assets (USD)$2.32B$2.98B$4.49B$4.45B$4.48B$2.71B$3.56B$2.61B$2.75B$3.29B
Cash & equivalents (USD)$735.00M$1.23B$1.14B$2.04B$1.81B$1.23B$2.01B$1.05B$1.13B$1.42B
Current liabilities (USD)$705.00M$746.00M$1.80B$665.00M$1.24B$1.09B$2.77B$1.57B$1.55B$1.58B
Long-term debt (USD)$1.06B$1.18B$890.00M$1.14B$673.00M—————
Shareholders' equity (USD)$2.20B$2.75B$3.76B$4.61B$4.69B$10.74B$6.60B$5.75B$2.37B$2.72B
Reported in10-K 201910-K 202010-K 202110-K 202210-K 202310-K 202310-K 202410-K 202510-K 202610-K 2026

Columns are fiscal years, labeled by the month the year ended; scroll sideways on small screens. — means the company did not report the figure under the XBRL concepts we track.

Balance-sheet figures are point-in-time values on the last day of each fiscal year. Some companies (for example banks and insurers) do not present current assets and liabilities; those cells show —.

Source: SEC EDGAR XBRL company facts for CIK 1110803 (raw data). Most recent filing in this dataset: 10-Q filed Oct 30, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.